Annette Von Drygalski
Director of Center for Bleeding and Clotting Disorders · University of California (San Diego) Medical Center
Credentials: · · · ·
History
PresentCenter for Bleeding and Clotting Disorders · University of California (San Diego) Medical Center
- 1998–1999
Hematology
- 1995–1998
Internal Medicine
- 1991–1995
Doctor of Medicine
Research
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
New England Journal of Medicine · 2023 · 303 citations
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
Journal of Clinical Investigation · 2013 · 198 citations
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
New England Journal of Medicine · 2023 · 178 citations
17 papers
- EC
16 papers
15 papers · 8 as a fellow
- RK
14 papers
8 papers
6 papers
6 papers
6 papers
Clinical trials
- 2025–2029
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Site PI · Recruiting · Phase 3
Takeda
- 2025–2028
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Site PI · Recruiting · Phase 3
Takeda
- 2020–2035
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Site PI · Recruiting
American Thrombosis and Hemostasis Network
- 2019–2026
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
Site PI · Unknown
Washington Institute for Coagulation